CARM
Price
$0.31
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Capitalization
12.75M
PMVP
Price
$1.48
Change
-$0.04 (-2.63%)
Updated
Aug 7, 10:35 AM (EDT)
Capitalization
78.97M
Earnings call today
Interact to see
Advertisement

CARM vs PMVP

Header iconCARM vs PMVP Comparison
Open Charts CARM vs PMVPBanner chart's image
Carisma Therapeutics
Price$0.31
Change-$0.00 (-0.00%)
Volume$136.78K
Capitalization12.75M
PMV Pharmaceuticals
Price$1.48
Change-$0.04 (-2.63%)
Volume$312
Capitalization78.97M
CARM vs PMVP Comparison Chart in %
Loading...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CARM vs. PMVP commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARM is a Hold and PMVP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (CARM: $0.31 vs. PMVP: $1.52)
Brand notoriety: CARM and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CARM: 1% vs. PMVP: 56%
Market capitalization -- CARM: $12.75M vs. PMVP: $78.97M
CARM [@Biotechnology] is valued at $12.75M. PMVP’s [@Biotechnology] market capitalization is $78.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARM’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • CARM’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, PMVP is a better buy in the long-term than CARM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARM’s TA Score shows that 4 TA indicator(s) are bullish while PMVP’s TA Score has 4 bullish TA indicator(s).

  • CARM’s TA Score: 4 bullish, 5 bearish.
  • PMVP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PMVP is a better buy in the short-term than CARM.

Price Growth

CARM (@Biotechnology) experienced а -9.17% price change this week, while PMVP (@Biotechnology) price change was +7.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.67%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +14.10%.

Reported Earning Dates

PMVP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PMVP($79M) has a higher market cap than CARM($12.8M). PMVP YTD gains are higher at: 0.662 vs. CARM (-27.125). CARM has higher annual earnings (EBITDA): -49.68M vs. PMVP (-87.97M). PMVP has more cash in the bank: 160M vs. CARM (7.74M). PMVP has less debt than CARM: PMVP (1.11M) vs CARM (2.33M). CARM has higher revenues than PMVP: CARM (20M) vs PMVP (0).
CARMPMVPCARM / PMVP
Capitalization12.8M79M16%
EBITDA-49.68M-87.97M56%
Gain YTD-27.1250.662-4,096%
P/E RatioN/AN/A-
Revenue20M0-
Total Cash7.74M160M5%
Total Debt2.33M1.11M210%
FUNDAMENTALS RATINGS
CARM: Fundamental Ratings
CARM
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CARMPMVP
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 25 days ago
84%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ECTM0.600.02
+4.33%
ECA Marcellus Trust I
IQEPF0.15N/A
N/A
IQE Plc
THYCF25.00N/A
N/A
Taiheiyo Cement Corp.
FNMAI13.14N/A
N/A
Fannie Mae
DNOPF12.50N/A
N/A
DINO POLSKA SA

CARM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CARM has been loosely correlated with EVGN. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CARM jumps, then EVGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARM
1D Price
Change %
CARM100%
-2.93%
EVGN - CARM
61%
Loosely correlated
-7.41%
INSM - CARM
43%
Loosely correlated
-0.31%
PMVP - CARM
32%
Poorly correlated
+2.70%
VCYT - CARM
31%
Poorly correlated
-4.16%
ADPT - CARM
30%
Poorly correlated
+5.79%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
+2.70%
CLLS - PMVP
39%
Loosely correlated
+7.11%
LRMR - PMVP
35%
Loosely correlated
+0.80%
MTVA - PMVP
35%
Loosely correlated
+2.92%
CMVLF - PMVP
34%
Loosely correlated
N/A
TERN - PMVP
34%
Loosely correlated
-6.74%
More